Global Glioblastoma Multiforme Treatment Market 2024-2028
상품코드:1603930
리서치사:TechNavio
발행일:2024년 10월
페이지 정보:영문 137 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
다형교아종치료 시장, 2024-2028년
다형교아종치료 시장은 2023-2028년에 13억 6,200만 달러, 예측 기간 중 CAGR은 8.2%로 성장할 것으로 예측됩니다. 다형교아종치료 시장의 전체적인 분석, 시장 규모·예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 다룬 벤더 분석 등을 게재하고 있습니다.
현재 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공하고 있습니다. 시장은 다형성교모세포종의 이환율 증가, 다형성교모세포종에 대한 정부의 호의적인 구상, 고령자의 증가에 의해 촉진되고 있습니다.
시장 범위
기준년
2024년
종료년
2028년
예측 기간
2024-2028년
성장 모멘텀
가속
전년대비[2024년]
7.4%
CAGR
8.2%
증분액
13억 6,200만 달러
본 조사에서는 향후 수년간 다형교아종치료 시장의 성장을 촉진하는 주요 요인의 하나로 연구개발 활동의 활발화를 들고 있습니다. 또한 혁신적인 바이오 시장의 개발 및 GBM에 대한 항균 바이러스 요법의 개발은 시장의 큰 수요로 연결될 것으로 생각되고 있습니다.
The glioblastoma multiforme treatment market is forecasted to grow by USD 1362 mn during 2023-2028, accelerating at a CAGR of 8.2% during the forecast period. The report on the glioblastoma multiforme treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of glioblastoma multiforme, favorable government initiatives for glioblastoma multiforme, and increasing geriatric population.
Market Scope
Base Year
2024
End Year
2028
Series Year
2024-2028
Growth Momentum
Accelerate
YOY 2024
7.4%
CAGR
8.2%
Incremental Value
$1362 mn
Technavio's glioblastoma multiforme treatment market is segmented as below:
By End-user
Hospitals
Clinics
Ambulatory surgical centers
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)
This study identifies the increasing research and development activities as one of the prime reasons driving the glioblastoma multiforme treatment market growth during the next few years. Also, development of innovative bio-market and development of oncolytic viral therapies for gbm will lead to sizable demand in the market.
The report on the glioblastoma multiforme treatment market covers the following areas:
Glioblastoma Multiforme Treatment Market sizing
Glioblastoma Multiforme Treatment Market forecast
Glioblastoma Multiforme Treatment Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading glioblastoma multiforme treatment market vendors that include AIVITA Biomedical Inc., Amgen Inc., Amneal Pharmaceuticals Inc., Angiochem Inc., Arbor Pharmaceuticals LLC, AstraZeneca Plc, Bayer AG, Bristol Myers Squibb Co., Chimerix Inc., DNAtrix Inc., F. Hoffmann La Roche Ltd., Karyopharm Therapeutics Inc., Kazia Therapeutics Ltd., Medicenna Therapeutics Corp., Merck and Co. Inc., Pfizer Inc., Sumitomo Pharma Co. Ltd., and Sun Pharmaceutical Industries Ltd.. Also, the glioblastoma multiforme treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Glioblastoma Multiforme Treatment Market 2018 - 2022
Historic Market Size - Data Table on Global Glioblastoma Multiforme Treatment Market 2018 - 2022 ($ million)
